Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects.
Spina
E
E
Institute of Pharmacology, University of Messina, Italy.
Ancione
M
M
Di Rosa
A E
AE
Meduri
M
M
Caputi
A P
AP
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000378:metabolism; D003647:Debrisoquin / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D010641:Phenotype; D011110:Polymorphism, Genetic; D012189:Retrospective Studies
D014150:Antipsychotic Agents; D003647:Debrisoquin